Tiemann Investment Advisors LLC bought a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 2nd quarter, Holdings Channel.com reports. The fund bought 3,230 shares of the company’s stock, valued at approximately $767,000.
Several other hedge funds also recently bought and sold shares of the company. LWM Advisors Inc. grew its holdings in shares of Cardinal Health by 4.4% in the 2nd quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock valued at $244,000 after buying an additional 43 shares during the period. Kathmere Capital Management LLC raised its stake in Cardinal Health by 1.2% during the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after buying an additional 49 shares during the period. Hillsdale Investment Management Inc. lifted its holdings in Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in Cardinal Health by 2.6% during the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after acquiring an additional 50 shares in the last quarter. Finally, Generali Asset Management SPA SGR grew its stake in Cardinal Health by 11.0% in the fourth quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after acquiring an additional 51 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Cardinal Health Price Performance
Shares of Cardinal Health stock opened at $235.68 on Tuesday. The firm has a market cap of $54.81 billion, a price-to-earnings ratio of 32.60, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. The stock’s 50-day moving average is $230.93 and its 200-day moving average is $217.34. Cardinal Health, Inc. has a one year low of $145.87 and a one year high of $258.30.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio is 28.49%.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the company. Barclays increased their price target on Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday. Bank of America increased their target price on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Weiss Ratings upgraded shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Wednesday, August 5th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Evercore reiterated an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $265.93.
Read Our Latest Stock Report on CAH
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
